R

Repligen Corp

RGEN

165.630
USD
-1.97
(-1.18%)
مفتوح الان
حجم التداول
6,054
الربح لكل سهم
0
العائد الربحي
0
P/E
-4,859
حجم السوق
8,125,982,795
أصول ذات صلة
B
BEAM
-1.310
(-4.14%)
30.330 USD
C
CDNA
3.680
(18.46%)
23.610 USD
C
CRSP
-2.450
(-4.28%)
54.840 USD
E
EDIT
-0.28500
(-5.26%)
5.13500 USD
G
GH
-1.770
(-5.04%)
33.380 USD
N
NTLA
-1.100
(-4.19%)
25.130 USD
N
NVTA
0
(0%)
0.000000 USD
P
PSTG
-3.110
(-5.19%)
56.830 USD
REGN
13.14
(1.22%)
1,091.19 USD
V
VCYT
-1.040
(-4.34%)
22.940 USD
VRTX
9.75
(1.97%)
505.40 USD
الأخبار المقالات

العنوان: Repligen Corp

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.